more generic ARBs in 2012

March 2012

You'll see more generic ARBs in 2012...irbesartan (Avapro) in March...valsartan (Diovan) in Sept...and candesartan (Atacand) in Dec.

But don't let this lure you into using them first-line instead of ACE inhibitors. ACEIs still have more evidence for improving outcomes.

When you do use an ARB, expect formularies to force switching from brand to generic.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology new Chest guidelines will create more debate about which anticoagulant to use to prevent strokes in atrial fib patients
Cardiology more generic ARBs in 2012
Gastroenterology new warnings that PPIs (omeprazole, etc) might increase the risk of Clostridium difficile-associated diarrhea
Women's Health whether it's okay for women with migraine headaches to use combined oral contraceptives
Diabetes Bydureon (by-DUR-ee-on), the new long-acting form of Byetta (exenatide) for type 2 diabetes
Dermatology Picato (pih-KAY-toe) gel as a more convenient topical treatment for actinic keratosis
Dermatology Many OTCs for bruises and scars don't work
Infectious Diseases fewer options for treating pinworms now that mebendazole (Vermox, etc) is discontinued
Antithrombotics whether it's okay to use aspirin to prevent thrombosis after hip or knee replacement surgery
Opioids how to handle drug interaction alerts for tramadol
Practice if their meds contain animal products
Neurology & Pain You'll get questions about what works for essential tremor